PK

Priyanka Kalita

Active Director Director DIN 08726629
DIN 08726629 First appointment Mar 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2020
Shareholding value •••• Premium profile

About Priyanka Kalita

Data last updated:

Priyanka Kalita is a Director at Medihine Pharmaceutical Private Limited (since 2020). The company operates in Pharma. Medihine Pharmaceutical Private Limited reported revenue of ₹13.7 Lakh (FY 2024).

DIN 08726629
Primary Designation Director
Industry Pharma
First Appointment 18 Mar 2020
Oldest Company Age 6 yrs
Largest company Medihine Pharmaceutical Private Limited · ₹13.7 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Mar 20202020₹13.7 Lakh (FY 2024)Active

Board colleagues of Priyanka Kalita

NameDINCompanyDesignation
Gautam Das08726628Medihine Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medihine Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Priyanka Kalita

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka Kalita

Priyanka Kalita currently holds 1 directorship: Medihine Pharmaceutical Private Limited (Director, since 18 Mar 2020, revenue ₹13.7 Lakh (FY 2024)).

Priyanka Kalita was first appointed on 18 Mar 2020 as Director at Medihine Pharmaceutical Private Limited.

The current boards of Priyanka Kalita's companies include Gautam Das (Medihine Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available